Therapeutically Targeted Destabilization of the Quaternary Structure of the Spike Protein in the Dominant G614 Strain of SARS-CoV-2-Reference-Cited by-同舟云学术

Therapeutically Targeted Destabilization of the Quaternary Structure of the Spike Protein in the Dominant G614 Strain of SARS-CoV-2

Published:2020-09-01 Issue:5 Volume:3 Page:1027-1029
ISSN:2575-9108
Container-title:ACS Pharmacology & Translational Science
language:en
Short-container-title:ACS Pharmacol. Transl. Sci.

Author:

Fernández Ariel¹^ORCID

Affiliation:

1. Daruma Institute for AI in Pharmaceutical Research, AF Innovation Pharma Consultancy, 4000 Pemberton Court, Winston-Salem, North Carolina 27106, United States

Publisher

American Chemical Society (ACS)

Subject

Pharmacology (medical),Pharmacology

Link

https://pubs.acs.org/doi/pdf/10.1021/acsptsci.0c00114

Reference12 articles.

1. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

2. Hu, J., He, C.L., Gao, Q.Z., Zhang, G.J., Cao, X.X., Long, Q.X., Deng, H.J., Huang, L.Y., Chen, J., and Wang, K., The D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity and decreases neutralization sensitivity to individual convalescent sera. bioRxiv (Microbiology), June 20, 2020. https://doi.org/10.1101/2020.06.20.161323.

3. Ozono, S., Zhang, Y., Ode, H., Seng, T. T., Imai, K., Miyoshi, K., Kishigami, S., Ueno, T., Iwatani, Y., Suzuki, T., and Tokunaga, K. Naturally mutated spike proteins of SARS-CoV-2 variants show differential levels of cell entry. bioRxiv (Microbiology), June 15, 2020, https://doi.org/10.1101/2020.06.15.151779.

4. Structural Impact of Mutation D614G in SARS-CoV-2 Spike Protein: Enhanced Infectivity and Therapeutic Opportunity

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Critical Mutations of the SARS-CoV-2 Virus;WSEAS TRANSACTIONS ON BIOLOGY AND BIOMEDICINE;2022-01-27

2. Rapid, inexpensive methods for exploring SARS CoV-2 D614G mutation;Meta Gene;2021-12

3. Rapid, inexpensive methods for exploring SARS CoV-2 D614G mutation;2021-04-19

4. Defusing SARS-CoV-2: Emergency Brakes in a Vaccine Failure Scenario;ACS Pharmacology & Translational Science;2020-10-15